Clinical HCC samples suggested positive associations between circ-ASAP1 expression and levels of CSF-1, MAPK1, and CD68+ tumor-related-macrophages; all these could predict patient outcomes [57]. The gene discussed is CSF1; the disease is hepatocellular carcinoma.